Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianjun Han

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|March 30, 2021
circKLHL24 Blocks Breast Cancer Development by Regulating the miR-1204/<i>ALX4</i> NetworkGuangming Yi, Dan Wang, Jianjun Han, et al.
European Journal of Pharmacology|July 22, 2022
The hypoxia-inducible factor 1 inhibitor LW6 mediates the HIF-1α/PD-L1 axis and suppresses tumor growth of hepatocellular carcinoma in vitro and in vivoHuirong Xu, Yeqiang Chen, Zhongchao Li, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|June 26, 2015
[Expression of high mobility group box-1 in colorectal cancer and its clinical significance]Zengjun Li, Haipeng Wang, Bao Song, et al.
Journal of Biochemical and Molecular Toxicology|October 23, 2023
Circ_0001982 aggravates breast cancer development through the circ_0001982-miR-144-3p-GSE1 axisFei Gao, Jianjun Han, Li Jia, et al.
World Journal of Surgical Oncology|March 2, 2016
Robotic versus laparoscopic low anterior resection for rectal cancer: a meta-analysisYanlai Sun, Huirong Xu, Zengjun Li, et al.
Discover Oncology|April 10, 2025
Intrahepatic cholangiocarcinoma patient with epidermal growth factor receptor exon 19 deletion unresponsive to Afatinib monotherapy: a case reportCaijiu Deng, Junming Huang, Qian Yu, et al.
Laboratory Medicine|June 13, 2025
The impact of anti-M antibodies on patient blood typing and transfusion safety: a retrospective studyXusheng Chen, Shilong Zhang, Jingyi Bi, et al.
Digestive Diseases (Basel, Switzerland)|December 6, 2018
Upregulation of Fibroblast Growth Factor 19 Is Associated with the Initiation of Colorectal AdenomaDongyang Wang, Jianjun Zhang, Zengjun Li, et al.
Oncotargets and Therapy|October 30, 2016
Comparison of the efficacy and tolerability of gefitinib with pemetrexed maintenance after first-line platinum-based doublet chemotherapy in advanced lung adenocarcinoma: single-center experienceLiping Lin, Juanjuan Zhao, Jiazhu Hu, et al.
Bosnian Journal of Basic Medical Sciences|June 21, 2018
Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathwayJianjun Han, Jingjing Yu, Yu'na Dai, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Cancer Biotherapy & Radiopharmaceuticals|March 30, 2021
circKLHL24 Blocks Breast Cancer Development by Regulating the miR-1204/<i>ALX4</i> NetworkGuangming Yi, Dan Wang, Jianjun Han, et al.
European Journal of Pharmacology|July 22, 2022
The hypoxia-inducible factor 1 inhibitor LW6 mediates the HIF-1α/PD-L1 axis and suppresses tumor growth of hepatocellular carcinoma in vitro and in vivoHuirong Xu, Yeqiang Chen, Zhongchao Li, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|June 26, 2015
[Expression of high mobility group box-1 in colorectal cancer and its clinical significance]Zengjun Li, Haipeng Wang, Bao Song, et al.
Journal of Biochemical and Molecular Toxicology|October 23, 2023
Circ_0001982 aggravates breast cancer development through the circ_0001982-miR-144-3p-GSE1 axisFei Gao, Jianjun Han, Li Jia, et al.
World Journal of Surgical Oncology|March 2, 2016
Robotic versus laparoscopic low anterior resection for rectal cancer: a meta-analysisYanlai Sun, Huirong Xu, Zengjun Li, et al.
Discover Oncology|April 10, 2025
Intrahepatic cholangiocarcinoma patient with epidermal growth factor receptor exon 19 deletion unresponsive to Afatinib monotherapy: a case reportCaijiu Deng, Junming Huang, Qian Yu, et al.
Laboratory Medicine|June 13, 2025
The impact of anti-M antibodies on patient blood typing and transfusion safety: a retrospective studyXusheng Chen, Shilong Zhang, Jingyi Bi, et al.
Digestive Diseases (Basel, Switzerland)|December 6, 2018
Upregulation of Fibroblast Growth Factor 19 Is Associated with the Initiation of Colorectal AdenomaDongyang Wang, Jianjun Zhang, Zengjun Li, et al.
Oncotargets and Therapy|October 30, 2016
Comparison of the efficacy and tolerability of gefitinib with pemetrexed maintenance after first-line platinum-based doublet chemotherapy in advanced lung adenocarcinoma: single-center experienceLiping Lin, Juanjuan Zhao, Jiazhu Hu, et al.
Bosnian Journal of Basic Medical Sciences|June 21, 2018
Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathwayJianjun Han, Jingjing Yu, Yu'na Dai, et al.
Pageof 9